Advertisement
Screener

Gratus Capital, LLC Historic Quarter Change: Foreign Stocks, Reduced

Gratus Capital, LLC historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 9 quarters from 2014-12-31 to 2024-06-30, Gratus Capital, LLC opened 14 positions, added to 7, reduced 5 and sold out of 2.

  • Q2 2024: Stock TEVA; Country of operation —; Class SPONSORED ADS; Shares before 770,133.
  • Q3 2016: Stock SSL; Country of operation —; Class SPONSORED ADR; Shares before 13,800.
  • Q3 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 18,542.
  • Q3 2016: Stock IBN; Country of operation —; Class ADR; Shares before 20,097.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1652103), 9 quarters: Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-25); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-13); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-03); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-11); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-09); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-06); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-29); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-09-29). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2024TEVA
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS770,133760,289-9,844$10,866,577$12,354,697+$1,488,1202024-07-25
Q3 2016SSL
SASOL LTD
SPONSORED ADR13,8009,800-4,000$374,000$268,000-$106,0002016-11-14
Q3 2016NVS
NOVARTIS A G
SPONSORED ADR18,54218,149-393$1,530,000$1,433,000-$97,0002016-11-14
Q3 2016IBN
ICICI BK LTD
ADR20,09716,597-3,500$144,000$124,000-$20,0002016-11-14
Q1 2016ULXXXX
UNILEVER PLC
SPON ADR NEW5,8595,534-325$253,000$250,000-$3,0002016-05-11

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet